Sökning: WFRF:(Magnusson Yvonne 1957)
> (2015-2019) >
TGF-beta receptor t...
-
Busch, SusannGothenburg University,Göteborgs universitet,Sahlgrenska Cancer Center
(författare)
TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer
- Artikel/kapitelEngelska2015
Förlag, utgivningsår, omfång ...
-
2013-12-16
-
Springer Science and Business Media LLC,2015
Nummerbeteckningar
-
LIBRIS-ID:oai:gup.ub.gu.se/211813
-
https://gup.ub.gu.se/publication/211813URI
-
https://doi.org/10.1038/onc.2013.527DOI
-
https://lup.lub.lu.se/record/4223697URI
Kompletterande språkuppgifter
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Transforming growth factor-beta (TGF-beta) is a pleiotropic cytokine with the capability to act as tumour suppressor or tumour promoter depending on the cellular context. TGF-beta receptor type-2 (TGFBR2) is the ligand-binding receptor for all members of the TGF-beta family. Data from mouse model experiments demonstrated that loss of Tgfbr2 expression in mammary fibroblasts was linked to tumour initiation and metastasis. Using a randomised tamoxifen trial cohort including in total 564 invasive breast carcinomas, we examined TGFBR2 expression (n = 252) and phosphorylation level of downstream target SMAD2 (pSMAD2) (n = 319) in cancer-associated fibroblasts (CAFs) and assessed links to clinicopathological markers, prognostic and treatment-predictive values. The study revealed that CAF-specific TGFBR2 expression correlated with improved recurrence-free survival. Multivariate analysis confirmed CAF-TGFBR2 to be an independent prognostic marker (multivariate Cox regression, hazard ratio: 0.534, 95% (CI): 0.360-0.793, P = 0.002). CAF-specific pSMAD2 levels, however, did not associate with survival outcome. Experimentally, TGF-beta signalling in fibroblasts was modulated using a TGF-beta ligand and inhibitor or through lentiviral short hairpin RNA-mediated TGFBR2-specific knockdown. To determine the role of fibroblastic TGF-beta pathway on breast cancer cells, we used cell contact-dependent cell growth and clonogenicity assays, which showed that knockdown of TGFBR2 in CAFs resulted in increased cell growth, proliferation and clonogenic survival. Further, in a mouse model transfected CAFs were co-injected with MCF7 and tumour weight and proportion was monitored. We found that mouse xenograft tumours comprising TGFBR2 knockdown fibroblasts were slightly bigger and displayed increased tumour cell capacity. Overall, our data demonstrate that fibroblast-related biomarkers possess clinically relevant information and that fibroblasts confer effects on breast cancer cell growth and survival. Regulation of tumour-stromal cross-talk through fibroblastic TGF-beta pathway may depend on fibroblast phenotype, emphasising the importance to characterise tumour microenvironment subtypes.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Acar, A.
(författare)
-
Magnusson, Yvonne,1957Gothenburg University,Göteborgs universitet,Sahlgrenska Cancer Center(Swepub:gu)xmagyv
(författare)
-
Gregersson, PernillaGothenburg University,Göteborgs universitet,Sahlgrenska Cancer Center(Swepub:gu)xgregp
(författare)
-
Rydén, LisaLund University,Lunds universitet,Kirurgi, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Surgery (Lund),Section V,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)pat-lry
(författare)
-
Landberg, Göran,1963Gothenburg University,Göteborgs universitet,Sahlgrenska Cancer Center(Swepub:gu)xlgora
(författare)
-
Göteborgs universitetSahlgrenska Cancer Center
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Oncogene: Springer Science and Business Media LLC34:1, s. 27-380950-92321476-5594
Internetlänk
Hitta via bibliotek
-
Oncogene
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas